Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US.

MLA

Rosen, Virginia M., et al. “Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US.” PharmacoEconomics, vol. 28, no. 1, Jan. 2010, pp. 47–60. EBSCOhost, https://doi.org/10.2165/11531440-000000000-00000.

APA

Rosen, V. M., Taylor, D. C. A., Parekh, H., Pandya, A., Thompson, D., Kuznik, A., Waters, D. D., Drummond, M., & Weinstein, M. C. (2010). Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US. PharmacoEconomics, 28(1), 47–60. https://doi.org/10.2165/11531440-000000000-00000

Chicago

Rosen, Virginia M., Douglas C. A. Taylor, Hemangi Parekh, Ankur Pandya, David Thompson, Andreas Kuznik, David D. Waters, Michael Drummond, and Milton C. Weinstein. 2010. “Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US.” PharmacoEconomics 28 (1): 47–60. doi:10.2165/11531440-000000000-00000.